Literature DB >> 27262205

An Overview of Pharmaceutical Excipients: Safe or Not Safe?

Cátia G Abrantes1, Dinah Duarte1, Catarina P Reis2.   

Abstract

A medicine consists of 2 fundamental parts: the active pharmaceutical ingredient and the excipient. Most, if not all, medicines could not be made without the use of excipients. In the early times, the safety of excipients was overlooked and no specific safety tests were generally conducted. This fact has been changed over times and is currently being recognized that the excipient's toxicity is not negligible, because its direct interaction with the active pharmaceutical ingredient or between other excipients may occur, leading to a potential change in the relationship between effectiveness and toxicity. This review is intended to address the general status of the pharmaceutical excipients and to describe the safety assessment. As a summary, this review suggests the interest of simplifying the formulations as much as possible and the interest of reducing the number of excipients necessary to strictly meet the required functions. The risk/benefit ratio of an excipient should be always evaluated on the basis of not only its production and quality but also of its safety. Further research according to Good Manufacturing Practices, Guiding Principles in Toxicology Assessment, Good Laboratory Practices, and Good Distribution Practices requirements are needed and are fundamental for health safety, contributing to a comprehensive picture of this matter.
Copyright © 2016 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  drug interactions; excipients; pre-formulation; solid dosage form; stability; toxicology

Mesh:

Substances:

Year:  2016        PMID: 27262205     DOI: 10.1016/j.xphs.2016.03.019

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  9 in total

1.  X-ray-Based Techniques to Study the Nano-Bio Interface.

Authors:  Carlos Sanchez-Cano; Ramon A Alvarez-Puebla; John M Abendroth; Tobias Beck; Robert Blick; Yuan Cao; Frank Caruso; Indranath Chakraborty; Henry N Chapman; Chunying Chen; Bruce E Cohen; Andre L C Conceição; David P Cormode; Daxiang Cui; Kenneth A Dawson; Gerald Falkenberg; Chunhai Fan; Neus Feliu; Mingyuan Gao; Elisabetta Gargioni; Claus-C Glüer; Florian Grüner; Moustapha Hassan; Yong Hu; Yalan Huang; Samuel Huber; Nils Huse; Yanan Kang; Ali Khademhosseini; Thomas F Keller; Christian Körnig; Nicholas A Kotov; Dorota Koziej; Xing-Jie Liang; Beibei Liu; Sijin Liu; Yang Liu; Ziyao Liu; Luis M Liz-Marzán; Xiaowei Ma; Andres Machicote; Wolfgang Maison; Adrian P Mancuso; Saad Megahed; Bert Nickel; Ferdinand Otto; Cristina Palencia; Sakura Pascarelli; Arwen Pearson; Oula Peñate-Medina; Bing Qi; Joachim Rädler; Joseph J Richardson; Axel Rosenhahn; Kai Rothkamm; Michael Rübhausen; Milan K Sanyal; Raymond E Schaak; Heinz-Peter Schlemmer; Marius Schmidt; Oliver Schmutzler; Theo Schotten; Florian Schulz; A K Sood; Kathryn M Spiers; Theresa Staufer; Dominik M Stemer; Andreas Stierle; Xing Sun; Gohar Tsakanova; Paul S Weiss; Horst Weller; Fabian Westermeier; Ming Xu; Huijie Yan; Yuan Zeng; Ying Zhao; Yuliang Zhao; Dingcheng Zhu; Ying Zhu; Wolfgang J Parak
Journal:  ACS Nano       Date:  2021-03-02       Impact factor: 15.881

2.  Investigating the stabilisation of IFN-α2a by replica exchange molecular dynamics simulation.

Authors:  Daixi Li; Peiqin Chen; Qingli Dong; Baolin Liu; Wujie Zhang; Dong-Qing Wei; Baisong Guo
Journal:  J Mol Model       Date:  2022-07-26       Impact factor: 2.172

3.  Historical Evolution and Provider Awareness of Inactive Ingredients in Oral Medications.

Authors:  Daniel Reker; Steven M Blum; Peter Wade; Christoph Steiger; Giovanni Traverso
Journal:  Pharm Res       Date:  2020-10-29       Impact factor: 4.200

4.  Preparation and Characterization of Co-Processed Mannitol and Sorbitol Using NanoCrySP Technology.

Authors:  Srilaxmi G Rao; Prashantkumar K Parmar; Katangur Vishruth Reddy; Arvind K Bansal
Journal:  AAPS PharmSciTech       Date:  2021-07-06       Impact factor: 3.246

5.  Development and Mechanistic Insight into the Enhanced Cytotoxic Potential of Parvifloron D Albumin Nanoparticles in EGFR-Overexpressing Pancreatic Cancer Cells.

Authors:  Ana Santos-Rebelo; Pradeep Kumar; Viness Pillay; Yahya E Choonara; Carla Eleutério; Mariana Figueira; Ana S Viana; Lia Ascensão; Jesús Molpeceres; Patrícia Rijo; Isabel Correia; Joana Amaral; Susana Solá; Cecília M P Rodrigues; Maria Manuela Gaspar; Catarina Pinto Reis
Journal:  Cancers (Basel)       Date:  2019-11-05       Impact factor: 6.639

Review 6.  The Role of Functional Excipients in Solid Oral Dosage Forms to Overcome Poor Drug Dissolution and Bioavailability.

Authors:  Jannes van der Merwe; Jan Steenekamp; Dewald Steyn; Josias Hamman
Journal:  Pharmaceutics       Date:  2020-04-25       Impact factor: 6.321

Review 7.  Dendrimers as Pharmaceutical Excipients: Synthesis, Properties, Toxicity and Biomedical Applications.

Authors:  Ana Santos; Francisco Veiga; Ana Figueiras
Journal:  Materials (Basel)       Date:  2019-12-21       Impact factor: 3.623

8.  Development of a Hot-Melt-Extrusion-Based Spinning Process to Produce Pharmaceutical Fibers and Yarns.

Authors:  Christoph Rosenbaum; Linus Großmann; Ellen Neumann; Petra Jungfleisch; Emre Türeli; Werner Weitschies
Journal:  Pharmaceutics       Date:  2022-06-10       Impact factor: 6.525

9.  Preclinical Safety Assessment of Chemically Cross-Linked Modified Mandua Starch: Acute and Sub-Acute Oral Toxicity Studies in Swiss Albino Mice.

Authors:  Mayank Kumar Malik; Pankaj Bhatt; Jaspal Singh; Rajneesh Dutt Kaushik; Gaurav Sharma; Vipin Kumar
Journal:  ACS Omega       Date:  2022-09-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.